The clinical sites for the first two years of RAD-PD have been selected. Ten participating sites will enroll patients in the first year and ten additional sites will be added in the second year, with the potential for more in the future.
Interested sites should contact the RAD-PD Project Manager for more information.
About Deep Brain Stimulation for Parkinson’s Disease
Deep brain stimulation (DBS) is the most common surgical treatment for Parkinson’s disease. While, DBS treatment does not slow down the disease or restore sick and dying nerve cells affected by Parkinson’s disease, it offers symptomatic benefits.
Deep brain stimulation treatment involves implanting a thin electrode into the brain and targets motor circuits that are not functioning properly. Small electrical pulses from a device stimulate a small region of the brain and block the signals that cause some Parkinson’s symptoms.
Enrollment in RAD-PD should be presented to all patients who are diagnosed with Parkinson’s disease and are eligible for DBS treatment.
Patients will be evaluated at baseline before surgery and followed longitudinally for up to five years. They will interact with study staff and complete patient-reported outcome measures via a patient portal called Outcomes and Unanswered Questions Registry for DBS (OUR-DBS). The portal provides participants with study updates and measures their progress with DBS over time.
If you have questions about participating, click here.